ADVANCED COOLING TECHNOLOGIES INC — Department of Defense SBIR Phase II: DHA PHASE II SBIR PSORALEN-UV-A IRRADIATION BASED HIGH-THROUGHPUT PATHOGEN INACTIVATION DE
ADVANCED COOLING TECHNOLOGIES INC — SBIR Phase II award from Department of Defense.
Phase II SBIR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,935 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Advanced Cooling Technologies Inc. won a $1.3 million Phase II SBIR award from the Defense Health Agency to build a device that uses Psoralen and UV-A light to rapidly inactivate pathogens. The goal is a high-throughput system suitable for medical use.
- Amount
- $1,299,935
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- PA
- Period
- 2025-07-02 → 2027-11-01
Technology domains
Description
DHA PHASE II SBIR PSORALEN-UV-A IRRADIATION BASED HIGH-THROUGHPUT PATHOGEN INACTIVATION DEVICE